National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 6) (PB 73 of 2016) (Cth)

PB 73 of 2016

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 6)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Determination under section 85B of the National Health Act 1953.

Dated 5 August        2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 6).

(2)        This Instrument may also be cited as PB 73 of 2016.

2          Commencement

This Instrument commences on 1 September 2016.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, omit entry for Imipramine

[2] Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g

omit from the column headed “Brand”:         Elocon                 substitute:             Elocon Alcohol Free

[3] Schedule 1, omit entry for Phenoxymethylpenicillin